AZN
NYSE
$164.40
Astrazeneca plc (AZN)
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $213.89 (+30.10%)
Market Cap
$296B
PEG Ratio
0.84
Dividends 5Y CAGR
+21.54%
Profit Margin
20.2%
Price Chart
Valuation
Market Cap$296B
P/E28.44
Forward P/E16.39
PEG0.84
P/S4.58
P/B6.20
Profitability
Total Revenue (TTM)$60B
Gross Profit (TTM)$49B
EBITDA$20B
Profit Margin20.2%
Operating Margin27.8%
EPS$6.66
Financial Health
Debt-to-Equity71.7%
Free Cash Flow Yield2.73%
Dividend Yield1.89%
Growth & Risk
EPS 5Y CAGR+17.09%
Revenue 5Y CAGR+16.99%
FCF 5Y CAGR+15.68%
Dividends 5Y CAGR+21.54%
Beta (5Y)0.36
Sharpe Ratio0.68